Synopsis of recent research by authors named "Alfonso Del Pozo"
Alfonso Del Pozo's recent research focuses heavily on the clinical aspects of COVID-19, particularly examining readmission rates and risk factors associated with the disease in a regional Spanish hospital.
He also investigated the effectiveness of ivermectin in treating COVID-19 pneumonia, aiming to reduce mortality and the necessity for respiratory support among hospitalized patients.
Additionally, Del Pozo has developed innovative pharmaceutical delivery systems, including hydrogels for localized treatment and lactose-free excipients to enhance medication accessibility for lactose-intolerant patients.
